Find out this week's new fundings, highlighted in yellow
| DECEMBER 2025 | |||
Organisation | Call | Deadline | Link |
| NIH NIDA | Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional) | 16 DEC 2025 | +info |
| NIH NIDA | Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Basic Experimental Studies with Humans Required) | 16 DEC 2025 | +info |
| NIH NIDA | Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional) | 16 DEC 2025 | +info |
| NIH NINDSNIAAA NIDA NIMH | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) | 15 DEC 2025 | +info |
| NIH NINDS NEI NIAAA NICHD NIDA NIMH | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) | 15 DEC 2025 | +info |
|
| NOVEMBER 2025 | |||
Organisation | Call | Deadline | Link |
| NIH NINDS | Translational Neural Devices (R61/R33 - Clinical Trial Optional) | 28 NOV 2025 | +info |
| Marie Sk?odowska-Curie Actions | MSCA Doctoral Networks 2025 | 25 NOV 2025 | +info |
| NIH NINDS NEI NIAAA NIDA NIMH | BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) | 20 NOV 2025 | +info |
| NIH NINDS NEI NIAAA NIDA NIMH | BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) | 20 NOV 2025 | +info |
| NIH NINDS NEI NIA NIAAA NIDCD NIDA NIMH | BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) | 20 NOV 2025 | +info |
| NIH NIDA | Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional) | 18 NOV 2025 | +info |
| OCTOBRE 2025 | |||
Organisation | Call | Deadline | Link |
| NIH NIA | Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) | 20 OCT 2025 | +info |
| NIH NEI NICHD NIDA NIMH NINDS | Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | 20 OCT 2025 | +info |
| NIH NEI NICHD NIDA NIMH NINDS | Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | 20 OCT 2025 | +info |
| NIH NEI NICHD NIDA NIMH NINDS | Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | 20 OCT 2025 | +info |
| NIH NIDA | Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) | 19 OCT 2025 | +info |
| NIH NIDA | Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) | 16 OCT 2025 | +info |
| NIH NIDA NIAAA | Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional) | 16 OCT 2025 | +info |
| NIH NIDA | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics | 16 OCT 2025 | +info |
| NIH NIA | Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional) | 16 OCT 2025 | +info |
| NIH NIMH NIA | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) | 16 OCT 2025 | +info |
| NIH NIMH | Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional) | 16 OCT 2025 | +info |
| NIH NIMH | Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) | 16 OCT 2025 | +info |
| NIH NIA NIVHD | New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) | 16 OCT 2025 | +info |
| NIH NIDCD NINDS | Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed) | 16 OCT 2025 | +info |
| Marie Sk?odowska-Curie Actions | MSCA Staff Exchanges 2025 | 8 OCT 2025 | +info |
| NIH NIDCD NINDS | Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed) | 5 OCT 2025 | +info |
| NIH NIA NIVHD | New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) | 5 OCT 2025 | +info |
| NIH NIMH NEI NIDA | Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) | 5 OCT 2025 | +info |
| NIH NIMH NIA | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) | 5 OCT 2025 | +info |
| NIH NIMH | Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders | 5 OCT 2025 | +info |
| NIH NIDA NIMH | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics | 5 OCT 2025 | +info |
NIH NIMH NIA | Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed) | 5 OCT 2025 | |
| NIH NIMH | Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional) | 5 OCT 2025 | +info |
| NIH NIMH | Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) | 5 OCT 2025 | +info |
NIH NIMH NIA | Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders | 5 OCT 2025 |
| SEPTEMBER 2025 | |||
Organisation | Call | Deadline | Link |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) | 16 SEP 2025 | +info |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) | 16 SEP 2025 | +info |
| NIH NIAAA | Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) | 16 SEP 2025 | +info |
| NIH NIMH | Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) | 16 SEP 2025 | +info |
| NIH NEI NIA NIAAA NIDCD NIDA NINDS | BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) | 10 SEP 2025 | +info |
| NIH NEI NIA NIAAA NIDCD NIDA NINDS | BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional) | 10 SEP 2025 | +info |
| Marie Skodowska-Curie Actions | MSCA Postdoctoral Fellowships 2025 | 10 SEP 2025 | +info |
| NIH NIDA NEI NIA NIAAA NIMH NINDS | BRAIN Initiative: Brain-Behavior Quantification and Synchronization – Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trial Optional) | 9 SEP 2025 | +info |
| NIH NIDA NEI NIA NIAAA NIMH NINDS | BRAIN Initiative: Brain-Behavior Quantification and Synchronization – Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trials Not Allowed) | 9 SEP 2025 | +info |
| NIH NIDA | Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) | 9 SEP 2025 | |
NIH NIDA | Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required) | 9 SEP 2025 | +info |
NIH NIDA |
| 9 SEP 2025 | +info |
| NIH NIMH NIA NIAAA NIDA NINDS | BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) | 7 SEP 2025 | +info |
| NIH NIDA NIAA NIMH | NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed) | 7 SEP 2025 | +info |
| NIH NIA | Analytical and Clinical Validation of Biomarkers for Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional) | 5 SEP 2025 | +info |
| NIH NIAAA | Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) | 5 SEP 2025 | +info |
| NIH NIMH | Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) | 5 SEP 2025 | +info |
| NIH NIAAA | Alcohol Health Services Research (R01 Clinical Trial Optional) | 5 SEP 2025 | +info |
| NIH NIMH | Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) | 5 SEP 2025 | +info |
| AUGUST 2025 | |||
Organisation | Call | Deadline | Link |
| Neuroschool | Scholarships to go to thematic schools in 2024-25 | 31 AUG 2025 | +info |
| ERC | 2025 Advanced Grant | 28 AUG 2025 | +info |
| Friedrich Ataxia Research Alliance (FARA) | General Research Grant | 15 AUG 2025 | +info |
| Friedrich Ataxia Research Alliance (FARA) | Postdoctoral Research Award | 15 AUG 2025 | +info |
| Friedrich Ataxia Research Alliance (FARA) | Postdoctoral Fellowship | 15 AUG 2025 | +info |
| NIH NIMH NIE NIAAA NIDCD NINDS | BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) | 11 AUG 2025 | +info |
| NIH | Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity) | 8 AUG 2025 | +info |
| NIH | Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) | 8 AUG 2025 | +info |
| JULY 2025 | |||
Organisation | Call | Deadline | Link |
| NIH NINDS | Translational Neural Devices (R61/R33 - Clinical Trial Optional) | 29 JUL 2025 | +info |
| NIH NIDA | NIDA Avant-Garde Program for HIV and Substance Use Disorder Research | 15 JUL 2025 | +info |
| NIH NIDA | Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed) | 14 JUL 2025 | +info |
| NIH NIDA | Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional) | 14 JUL 2025 | +info |
| NIH NIDA | Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Basic Experimental Studies with Humans Required) | 14 JUL 2025 | +info |
| NIH NIDA | Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional) | 14 JUL 2025 | +info |
| NIH NIDA | Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed) | 14 JUL 2025 | +info |
| NIH NIDA | Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional) | 13 JUL 2025 | +info |
| NIH NIMH NEI NIAAA NIDA NINDS NICHD | BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) | 11 JUL 2025 | +info |
| JUNE 2025 | |||
Organisation | Call | Deadline | Link |
| NIH NIDA | Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) | 28 JUN 2025 | +info |
| Marie Sk?odowska-Curie Actions | MSCA COFUND 2025 | 24 JUN 2025 | +info |
| NIH NIA | Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) | 23 JUN 2025 | +info |
| BPI France | Challenge prévention : démontrer la valeur des innovations en vie réelle | 17 JUN 2025 | +info |
| NIH NEI NIAAA NIDCD NIDA NIMH NINDS | BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) | 17 JUN 2025 | +info |
| NIH NEI NICHD NIDA NIMH NINDS | Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | 17 JUN 2025 | +info |
| NIH NEI NICHD NIDA NIMH NINDS | Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | 17 JUN 2025 | +info |
| NIH NEI NICHD NIDA NIMH NINDS | Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | 17 JUN 2025 | +info |
| NIH NIDA | Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) | 17 JUN 2025 | +info |
| NIH NIDA NIAAA | Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional) | 16 JUN 2025 | +info |
NIH NIDA | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics | 16 JUN 2025 | +info |
| NIH NIMH NIA | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) | 16 JUN 2025 | +info |
| NIH NIA | Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional) | 16 JUN 2025 | +info |
| NIH NIMH | Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional) | 16 JUN 2025 | +info |
| NIH NIMH | Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) | 16 JUN 2025 | +info |
| NIH NIDA | Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) | 16 JUN 2025 | +info |
| NIH NIDCD NINDS | Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed) | 16 JUN 2025 | +info |
| NIH NIA NIVHD | New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) | 16 JUN 2025 | +info |
| NIH NINDSNIAAA NIDA NIMH | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) | 15 JUN 2025 | +info |
| NIH NINDS NEI NIAAA NICHD NIDA NIMH | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) | 15 JUN 2025 | +info |
| Fondation Apicil | Demande de subvention | 15 JUN 2025 | +info |
| NIH NIA NIVHD | New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) | 5 JUN 2025 | +info |
| NIH NIDCD NINDS | Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed) | 5 JUN 2025 | +info |
| NIH NIMH NEI NIDA | Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) | 5 JUN 2025 | +info |
| NIH NIMH | Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders | 5 JUN 2025 | +info |
NIH NIDA NIMH | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics | 5 JUN 2025 | +info |
NIH NIDA NIMH | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics | 5 JUN 2025 | +info |
| NIH NIMH NIA | Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders | 5 JUN 2025 | +info |
NIH NIDA | Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required) | 5 JUN 2025 | +info |
NIH NIMH NIA |
| 5 JUN 2025 | |
| NIH NIMH NIA | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) | 5 JUN 2025 | +info |
| MAY 2025 | |||
Organisation | Call | Deadline | Link
|
| NIH NIMH NEI NIA NIAAA NIDCD NIDA NINDS | BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) | 24 MAY 2025 | +info |
NIH NIDA |
| 20 MAY 2025 | +info |
NIH NIDA | Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required) | 20 MAY 2025 | +info |
| BPI France | Appel à projets : « Innovations en biothérapies et bioproduction » | 20 MAY 2025 | +info |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) | 16 MAY 2025 | +info |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) | 16 MAY 2025 | +info |
| NIH NIAAA | Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) | 16 MAY 2025 | +info |
| NIH NIAAA | Alcohol Health Services Research (R34 Clinical Trial Optional) | 16 MAY 2025 | +info |
| NIH NIMH | Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) | 16 MAY 2025 | +info |
| FEBS | 2026 FEBS | EMBO Women in Science Award | 15 MAY 2025 | +info |
| NIH NIMH | Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required) | 13 MAY 2025 | +info |
| NIH NIAAA | Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) | 5 MAY 2025 | +info |
| NIH NIAAA | Alcohol Health Services Research (R01 Clinical Trial Optional) | 5 MAY 2025 | +info |
| NIH NIMH | Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) | 5 MAY 2025 | +info |
| Leverhulme Trust | Visiting Professorships | 1 MAY 2025 | +info |
| APRIL 2025 | |||
Organisation | Call | Deadline | Link |
| Société de Biologie Cellulaire de France (SBCF) | Bourses de voyage | 15 APR 2025 | +info |
| BPI France | Appel à projets « Evaluation du bénéfice médico-économique des dispositifs médicaux numériques et des dispositifs médicaux d’équipement » | 8 APR 2025 | +info |
| NIH | Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) | 8 APR 2025 | +info |
| NIH | Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity) | 8 APR 2025 | +info |
| NIH NIDA NIAA NIMH | NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed) | 5 APR 2025 | +info |
| NIH NINDS NEI NIAAA NIDA NIMH | BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) | 2 APR 2025 | +info |
| NIH NINDS NEI NIAAA NIDA NIMH | BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) | 2 APR 2025 | +info |
| NIH NINDS NEI NIA NIAAA NIDCD NIDA NIMH | BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) | 2 APR 2025 | +info |
| MARCH 2025 | |||
Organisation | Call | Deadline | Link |
| NIH NINDS | Translational Neural Devices (R61/R33 - Clinical Trial Optional) | 28 MAR 2025 | +info |
| BPI France | Appel à projets : « Industrialisation et Capacités Santé 2030 » | 25 MAR 2025 | +info |
| Fondation Apicil | Demande de subvention | 15 MAR 2025 | +info |
| Marie Sklodowska-Curie Actions | MSCA Staff Exchanges 2024 | 5 MAR 2025 | +info |
| FEBRUARY 2025 | |||
Organisation | Call | Deadline | Link |
| Institut Français Slovaquie | Bourse de doctorat en cotutelle | 28 FEB 2025 | +info |
| NIH NIDA | Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) | 26 FEB 2025 | +info |
| NIH NIA | Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) | 21 FEB 2025 | +info |
| NIH NEI NICHD NIDA NIMH NINDS | Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | 20 FEB 2025 | +info |
| NIH NEI NICHD NIDA NIMH NINDS | Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | 20 FEB 2025 | +info |
| NIH NEI NICHD NIDA NIMH NINDS | Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | 18 FEB 2025 | +info |
| NIH NIA NIVHD | New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) | 16 FEB 2025 | +info |
| NIH NIDA NIAAA | Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional) | 16 FEB 2025 | +info |
NIH NIDA | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics | 16 FEB 2025 | +info |
| NIH NIA | Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional) | 16 FEB 2025 | +info |
| NIH NIMH NIA | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) | 16 FEB 2025 | +info |
| NIH NIDA | Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) | 16 FEB 2025 | +info |
| NIH NIMH | Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional) | 16 FEB 2025 | +info |
| NIH NIMH | Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) | 16 FEB 2025 | +info |
| NIH NIDCD NINDS | Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed) | 16 FEB 2025 | +info |
| Friedrich Ataxia Research Alliance (FARA) | General Research Grant | 15 FEB 2025 | +info |
| Friedrich Ataxia Research Alliance (FARA) | Postdoctoral Research Award | 15 FEB 2025 | +info |
| Friedrich Ataxia Research Alliance (FARA) | Postdoctoral Fellowship | 15 FEB 2025 | +info |
NIH NIDA | Exploratory Clinical Neuroscience Research on Substance Use Disorders | 13 FEB 2025 | +info |
| NIH NIDA | Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required) | 13 FEB 2025 | +info |
| NIH NICHD NIDCD | Omics Phenotypes Related to Down Syndrome for the INCLUDE Project (X01 Clinical Trial Not Allowed) | 13 FEB 2025 | +info |
| Children's Tumor Foundation | Prix ??de recherche clinique (CRA) | 10 FEB 2025 | +info |
| American Psychological Foundation (APF) | Beth N. Rom-Rymer Scholarships | 7 FEB 2025 | +info |
| NIH NINDS NIE NIA NIAAA NIDA | HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional) | 6 FEB 2025 | +info |
| Marie Sklodowska-Curie Actions | MSCA COFUND 2024 | 6 FEB 2025 | +info |
| NIH NIDCD NINDS | Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed) | 5 FEB 2025 | +info |
| NIH NIA NIVHD | New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) | 5 FEB 2025 | +info |
| NIH NIMH NEI NIDA | Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) | 5 FEB 2025 | +info |
| NIH NIMH | Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional) | 5 FEB 2025 | +info |
| NIH NIMH | Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) | 5 FEB 2025 | +info |
| NIH NIMH NIA | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) | 5 FEB 2025 | +info |
| NIH NIMH | Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders | 5 FEB 2025 | +info |
NIH NIDA |
| 5 FEB 2025 | +info |
NIH NIDA NIMH | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics | 5 FEB 2025 | +info |
NIH NIMH NIA | Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed) | 5 FEB 2025 | +info |
| Marie Sk?odowska-Curie Actions | MSCA Staff Exchanges 2024 | 5 FEB 2025 | +info |
| Parkinson's foundation | Visiting Scholar Awards | 3 FEB 2025 | +info |
| Children's Tumor Foundation | Initiative de découverte de médicaments (IDM) | 3 FEB 2025 | +info |
| NIH NIDA | Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) | 3 FEV 2025 | +info |
| Friedrich Ataxia Research Alliance (FARA) | Award for Innovative Mindset (AIM) | 1 FEB 2025 | +info |
| FRAXA | FRAXA Fellowship | 1 FEB 2025 | +info |
| JANUARY 2025 | |||
Organisation | Call | Deadline | Link |
| Alzheimer's Association | Program for Global Real-World Data Platforms (ALZ-RWD) | 31 JAN 2025 | +info |
| France-Berkeley Fund | Call for Projects (2025-27) | 31 JAN 2025 | +info |
| Foundation Fighting Blindness | Career Development Program (CDA) | 30 JAN 2025 | +info |
| EU4Health Programme (EU4H) | EU4H Action Grants 2024 (EU4H-2024-PJ-03) | 22 JAN 2025 | +info |
| NIH NIDA | Integrated Functional Mapping and Molecular Profiling of Cell Ensembles Encoding the Effects of Addictive Substances in Rodents (R01 Clinical Trial Not Allowed) | 21 JAN 2025 | +info |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) | 17 JAN 2025 | +info |
| American Epilepsy Society | Postdoctoral Research Fellowships | 16 JAN 2025 | +info |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) | 16 JAN 2025 | +info |
| NIH NIAAA | Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) | 16 JAN 2025 | +info |
| NIH NIAAA | Alcohol Health Services Research (R34 Clinical Trial Optional) | 16 JAN 2025 | +info |
| NIH NIMH | Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) | 16 JAN 2025 | +info |
| Eppendorf and Nature | Eppendorf Award for Young European Investigators | 15 JAN 2025 | +info |
| Fondation Apicil | Demande de subvention | 15 JAN 2025 | +info |
| Hereditary Disease Foundation | HDF Transformative Research Award | 15 JAN 2025 | +info |
| ERC | 2025 Consolidator Grant | 14 JAN 2025 | +info |
| Spencer Foundation | Research Grants on Education: Large | 14 JAN 2025 | +info |
| The Michael J. Fox Foundation | Personalized Approaches for Understanding, Assessing and Improving Gait in Parkinson’s Disease Research Program | 14 JAN 2025 | +info |
| ERC | 2025 Consolidator Grant | 14 JAN 2025 | +info |
| NIH NIDA NIAAA | Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional) | 14 JAN 2025 | +info |
| Parkinson's foundation | Melvin Yahr Parkinson’s Disease Clinical Research Award | 9 JAN 2025 | +info |
| NIH NIMH NIA NIAAA NIDA NINDS | BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) | 7 JAN 2025 | +info |
| NIH NIDA NIAA NIMH | NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed) | 6 JAN 2025 | +info |
| NIH NIA | Analytical and Clinical Validation of Biomarkers for Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional) | 5 JAN 2025 | +info |
| NIH NIMH | Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) | 5 JAN 2025 | +info |
| NIH NIAAA | Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) | 5 JAN 2025 | +info |
| NIH NIAAA | Alcohol Health Services Research (R01 Clinical Trial Optional) | 5 JAN 2025 | +info |
| NIH NIMH | Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) | 5 JAN 2025 | +info |